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Antje Damms-Machado1, Gesine Weser1 and Stephan C Bischoff2*Abstract
Background: The prevalence of micronutrient deficiencies is higher in obese individuals compared to normal-
weight people, probably because of inadequate eating habits but also due to increased demands among
overweight persons, which are underestimated by dietary reference intakes (DRI) intended for the general
population. We therefore evaluated the dietary micronutrient intake in obese individuals compared to a reference
population and DRI recommendations. Furthermore, we determined the micronutrient status in obese subjects
undergoing a standardized DRI-covering low-calorie formula diet to analyze if the DRI meet the micronutrient
requirements of obese individuals.
Methods: In 104 subjects baseline micronutrient intake was determined by dietary record collection. A randomly
assigned subgroup of subjects (n = 32) underwent a standardized DRI-covering low-calorie formula diet over a
period of three months. Pre- and post-interventional intracellular micronutrient status in buccal mucosa cells (BMC)
was analyzed, as well as additional micronutrient serum concentrations in 14 of the subjects.
Results: Prior to dietetic intervention, nutrition was calorie-rich and micronutrient-poor. Baseline deficiencies in
serum concentrations were observed for 25-hydroxyvitamin-D, vitamin C, selenium, iron, as well as ß-carotene,
vitamin C, and lycopene in BMC. After a three-month period of formula diet even more subjects had reduced
micronutrient levels of vitamin C (serum, BMC), zinc, and lycopene. There was a significant negative correlation
between lipophilic serum vitamin concentrations and body fat, as well as between iron and C-reactive protein.
Conclusions: The present pilot study shows that micronutrient deficiency occurring in obese individuals is not
corrected by protein-rich formula diet containing vitamins and minerals according to DRI. In contrast, micronutrient
levels remain low or become even lower, which might be explained by insufficient intake, increased demand and
unbalanced dispersal of lipophilic compounds in the body.
Trial registration: The study was registered at ClinicalTrials.gov (NCT01344525). The study protocol comprises only
a part of the approved trial protocol.
Keywords: Obesity, Low calorie diet, Weight loss, Micronutrient deficiency, Dietary reference intakeBackground
In general, occurrence of malnutrition is thought to be
disease-related and/or associated with undernourish-
ment. During the past few years, evidence has been
raised that obesity can also be associated with substantial
nutrient deficiencies [1-5]. In fact, the prevalence of
micronutrient deficiencies in obese individuals is higher
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distribution, and reproduction in any mediumand sex [6,7], and affects several micronutrients such as
zinc [4,8], selenium [4,6,8,9], folate [4,6,8,10], vitamin B1
[11], vitamin B12 [4,6,8,10,12], vitamin A [6,8], vitamin E
[4,6], and 25-hydroxyvitamin D [25(OH)D] [4,6,8,11].
Imbalances or deficiencies of essential micronutrients
significantly influence day-to-day performance, behavior
and emotional state, as well as intellectual and physical
activity [13-15]. It has been hypothesized that toxic by-
products of incomplete biochemical reactions resulting
from excessive intake of kilocalories and states of micro-
nutrient deficiencies could lead to further weight gain or
development of associated metabolic diseases [13,16].ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cant part of the population could be afflicted by this type
of micronutrient deficiency, even in wealthy Western
countries.
The dietary reference intakes (DRI) for daily supply of
vitamins and mineral nutrients apply to healthy, normal
weight individuals. They account for individual variations
and distinguish between age groups and sex [17,18], but
they do not apply to patients with metabolic alterations or
other disease, or individuals using pharmaceuticals on a
regular basis. Hence, DRI do not necessarily meet the
metabolic needs of obese individuals. Especially in physio-
logic stress situations like significant weight loss or periods
of weight cycling, obese patients potentially need different
amounts of micronutrients.
The first aim of this pilot study was to investigate the
micronutrient intake in obese subjects compared to a
reference population and DRI recommendations. Second
aim was to determine both serum and intracellular
micronutrient status after a standardized DRI-covering
low-calorie formula diet over three months in order to
analyze if DRI for micronutrients apply to obese patients
in a period of major weight loss. This setting was
chosen, because it offers a unique possibility to study
this issue using an entirely standardized diet consumed
by high-grade obese individuals over a longer-term
period.
Methods
Intervention and study population
This pilot study included obese individuals participating in
a multidisciplinary weight loss program (OPTIFASTW52)
causing an average weight loss of 26.0 kg in men and
19.6 kg in women within one year [19]. Briefly, the pro-
gram consists of a five-phase lifestyle modification program
designed for 52 weeks, including (i) a 1-week introduction
during which a detailed nutrition analysis is performed; (ii)
a 12 week period of low-calorie diet (LCD) (800 kcal/day)
during which participants consume a formula diet exclu-
sively (daily consumption of 5 sachets at 160 kcal each,
Optifast 800W formula, Nestlé Inc.); (iii) a 6 weeks refeed-
ing phase, (iv) a 7 weeks stabilization phase and (v) a
26 weeks maintenance phase. We previously reported
more detailed information about the program [19]. The
five daily consumed formula meals in the second phase
contain vitamins, minerals and trace elements according
to DRI for healthy adults (Table 1), except for the flavor
potato/leek, which contains less amounts of vitamin C,
vitamin B12, folate and calcium. However, flavor selection
was documented, recording that the latter one was only
consumed occasionally.
To determine micronutrient intake in obese indivi-
duals we analyzed dietary record data obtained during
the introduction week from all participants enrolledfrom 02/2006 to 02/2010 (n = 104). A randomly assigned
subgroup of subjects (n = 32) participated in a pilot
study, and was followed up for micronutrient measure-
ment before and after the three-month formula diet
period (LCD intervention group). Patients with a history
of bariatric surgery were excluded from study participa-
tion. The measurements were performed by intracellular
micronutrient analysis in buccal mucosa cells (BMC)
and by additional serum micronutrient analysis in 14 of
the subjects. The latter subjects did not differ in initial
body weight and weight loss to the whole LCD interven-
tion group. For 9 subjects, long-term data on intracellu-
lar vitamin concentrations were also obtained at the end
of the program year, 9 months after completion of the
LCD phase. The nutrients evaluated in this study were
vitamin C (BMC, serum, leukocytes), vitamin E (BMC,
serum), lycopene (BMC), β-carotene (BMC), vitamin A,
25(OH)D, vitamin B12, folate, selenium, iron, zinc and cal-
cium (all serum). Deficiency was defined as a concentra-
tion below the reference interval: vitamin A 0.2-1.2 mg/
ml, vitamin E 5–16 mg/ml (serum)/9.5-20.3 pmol/μg
DNA (BMC), 25(OH)D, 20–70 ng/ml, vitamin C 28.3-
85.1 μg/ml (serum)/57–114 nmol/108 cells (leukocytes)/
3.9-11.1 pmol/μg DNA (BMC), vitamin B12 191–663 pg/
ml, folate 4.6-18.7 ng/ml, selenium 74–139 μg/ml, iron
40–170 μg/dl, zinc 70–150 μg/dl, calcium 2.2-2.6 mmol/l,
β-carotene 0.1-05 pmol/μg DNA, and lycopene 0.1-05
pmol/μg DNA. Moreover, C-reactive protein (CRP) con-
centrations were analyzed in serum samples. Drug use was
monitored and documented on standardized forms. We
calculated body mass index (BMI) and relative weight loss
in percent (RWL; = 100xΔweight loss in kg/initial body
weight in kg). Body composition was analyzed using bio-
electrical impedance analysis at all study visits (Data Input
Nutriguard M, Darmstadt, Germany). The study protocol
was part of a multicenter clinical trial, research project
“Obesity and the gastrointestinal tract” (ClinicalTrials.gov
identifier: NCT01344525), approved by the ethics commit-
tee of the University Hospital of Tübingen, Germany.
Informed consent was obtained from every subject prior
to participation.
Dietary records
Food intake was recorded using a predesigned daily jour-
nal. Subjects had to document time, amount (in gram)
and situation, in which a food or beverage was consumed.
They were instructed to: (1) document all consumed foods
and beverages in as much detail as possible, (2) to weigh
foods (or to estimate doses, if weighing was not possible in
some situations), (3) to document food or beverage intake
immediately after consumption and (4) not to change
usual eating habits. Data analysis was performed using the
nutrition software EBISpro, version 8.0 for Windows. In
analyzing the eating records, nutrients were studied in
Table 1 Content of selected micronutrients in the formula diet and comparison with DRI (D-A-CH reference values)
Micronutrient Unit Per sachet flavor A (42 g) % of DRI per 5 sachets Per sachet flavor B (42 g) % of DRI per 5 sachets
Vitamin A mg 0.3 ♀188; ♂150 0.2 ♀125; ♂100
Vitamin D μg 1.0 101 1.2 118
Vitamin E mg 4.0 ♀142; ♂166 3.4 ♀122; ♂143
Vitamin C mg 20.0 100 10.8 54
Vitamin B12 μg 0.6 98 0.4 60
Folate μg 80.2 100 48.0 60
Calcium mg 290.6 145 168.1 84
Iron mg 4.0 ♂133; ♀199 3.8 ♂127; ♀191
Zinc mg 3.0 ♂149; ♀213 2.3 ♂114; ♀163
Selenium μg 20.2 144-336 13.6 97-227
Flavor A: vanilla, chocolate, strawberry, coffee, and tomato; flavor B: potato/leek.
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DRI utilized corresponds to the age group and sex. Fur-
thermore, data were compared with the Second National
Nutrition Survey (NNSII), which is representative for the
German population. The dietary assessment in this survey
was performed using controlled interviews according to
the diet history method, which were reinforced by dietary
record collection and 24 hour-recalls in a representative
sub-sample.
Intracellular micronutrient concentrations in buccal
mucosa cells (BMC)
BMC were collected using a kit from Day-med-concept
GmbH, Berlin, Germany. Subjects first had to rinse their
mouths with water thoroughly to remove food particles
and then brush the inner lining of their cheeks with a soft
toothbrush twenty times, twice on each side. The tooth-
brush was washed in 25 ml NaCl solution (0.9%) gently
after each brushing. The samples were then centrifuged at
1,600 rpm for 3 minutes. The supernatant was discarded;
the cells were completely resuspended in rinsing solution
(phosphor float 0.15%w/v) and centrifuged again at
1,800 rpm for 3 minutes. After removal of the supernatant
fraction, the stabilizing solution (heat-sensitive reducing
agent 0.09%w/v) was added; and the cells were resus-
pended and stored. The micronutrients in BMC (pmol/μg
DNA) of the samples were measured by BioTeSys GmbH
(Esslingen, Germany) using an accredited RP-HPLC
method according to DIN EN ISO/IEC 17025. The refer-
ence values are based on a statistical distribution reflecting
the 25th and 75th percentile of a data set covering ana-
lysed BMC samples over one year.
Micronutrient concentrations were expressed in pmol/
μg DNA. Micronutrient detection was possible when the
amount of DNA in BMC was at least sufficient (>1 μg).
If the amount of DNA extracted was< 1 μg, the data
was excluded from analysis. Micronutrients below detec-
tion limit were defined as suboptimal cellularconcentrations according to the analysis laboratory and
therefore were included.
Serum concentrations of micronutrients
For serum micronutrient analysis, blood was collected
by venipuncture between 8.00 a.m. and 10.00 a.m. after
an overnight fast. Serum was separated by centrifugation
at 2,000 x g for 15 min at 4°C. Aliquots were immedi-
ately stored at −80°C and sent to an external laboratory
on the same day. HPLC was used to assay vitamin A and
α-tocopherol. Measurement of vitamin C, calcium and
iron was performed by photometry. Furthermore, serum
was analyzed for 25(OH)D (radioimmunoassay), zinc
and selenium (atomic absorption spectrometry) and vita-
min B12 and folate (luminescence immunoassay).
Vitamin C concentrations in leukocytes
Isolation of leucocytes for vitamin C analysis was per-
formed immediately after blood withdrawal. Briefly, sedi-
mentation of erythrocytes was performed in a hermetic
tube in dark environment using 6% Dextran according to
the method of Denson et al. [20]. Supernatant was centri-
fuged for 10 min at 320 x g. After resuspension with HA
buffer lysis of remaining erythrocytes was performed by
5 min incubation with 10 ml ammonium chloride. After
centrifugation (10 min, 600 x g), leukocytes were manually
counted and pellets frozen at −80 °C until analysis. Deter-
mination of total ascorbic acid concentrations in leukocytes
was performed by HPLC. In summary, after thawing,
leukocyte pellets reducing agent (20 μl 20% TCEP solution
[tris (2- carboxyethyl) phosphine hydrochlorid]) was added,
thoroughly mixed and incubated on ice for 5 min. For cell
lysis 80 μl 10% meta-phosphoric acid was added, mixed
and centrifuged (10 min, 13,000 x g, 4°C). Ascorbic acid
concentrations in the supernatant were determined by UV/
VIS detector at 245 nm.
All samples for vitamin C analysis were rapidly pro-
cessed and shielded from light exposure.
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Values are expressed as means ± SD if not indicated
otherwise. For the comparison of dietary record para-
meters with the reference population, Gaussian distribu-
tion was assumed due to sample size (n = 15,371).
Differences between the obese study population and the
NNSII data were analyzed using unpaired t-tests. The
paired t-test was applied to compare repeated measures
of micronutrients. If Gaussian distribution could not be
assumed Wilcoxon signed-rank test was used instead of
t-tests. Frequencies were analyzed with cross tables
according to the method of McNemar. Analysis of co-
variance (ANCOVA) was performed to control for the
effect of sex, age, energy, and medication use on micro-
nutrient concentrations. Relations between continuous
variables were analyzed by calculating the Spearman´s
rank correlation coefficient or, in case of normal distri-
bution of the data, the Pearson’s correlation coefficient.
P values <0.001 were interpreted as statistically highly
significant, p-values between 0.001 and <0.01 as very
significant and p-values between 0.01 and <0.05 as sig-
nificant differences. All analyses were carried out by
using the statistics software SPSS, version 19.0
(IBMWSPSSW, Chicago, IL), and Graph Pad Prism, ver-
sion 5.0 (GraphPad Software, Inc., La Jolla, CA).Results
Baseline characteristics, weight loss and drug intake
Prior to intervention all subjects had at least grade I
obesity (BMI ≥ 30 kg/m2), about 50% even obesity grade
III (BMI ≥ 40 kg/m2). The obese study group (dietary
records) and the reference population were well matched
in respect to age, but the obese group comprised more
females (Table 2). BMI of the reference population was
significantly lower compared to the obese study group
(26.5 kg/m2 versus 40.9 kg/m2, p< 0.001). 32 out of 104
obese individuals (31%) underwent the LCD interven-
tion. On average, these subjects lost 16.2% of initial body
weight during the three-month LCD period. The LCD









Age 45.8 45.8 ± 11.0
Weight [kg] 76.7 117.8 ± 29.85
BMI [kg/m2] 26.5 40.9 ± 7.20
Data are presented as mean ± SD.until program end (12 months after start of interven-
tion), did not differ in weight loss during the LCD period
compared with the whole LCD intervention group
(Table 3).
86% of the subjects undergoing LCD took medication
on a regular basis, which may have resulted in drug-
nutrient interaction effects, thus influencing micronu-
trient bioavailability: ACE inhibitor (21%), proton pump
inhibitor (8%), antidepressants (14%), L-thyroxine (14%),
biguanide (7%), insulin (7%), loop diuretics (8%), NSAID
(7%) and xanthine oxidase inhibitor (14%). Frequencies
and dosage of medication decreased slightly in 36% of
the cases during the LCD period. Controlling for sex,
age, energy intake, and medication use, did not reveal
significant effects on micronutrient concentrations.Micronutrient intake
Micronutrient intakes in obese subjects are shown in
Table 4. Micronutrient intake in female subjects was sig-
nificantly lower for five micronutrients compared to the
reference population, in male subjects for six micronutri-
ents, respectively. Women consumed nine micronutrients
in amounts below DRI whereas with men this applied to
seven micronutrients. Lowest micronutrient intakes com-
pared to DRI were observed for retinol, ß-carotene, vitamin
D, folate, iron and iodine (>75% of the obese study popula-
tion below DRI) and vitamin E, C and calcium (>50%
respectively).
Micronutrient intake did not differ between the whole
study group (n = 104) and the subset of obese individuals
undergoing LCD, which were further subjected to intra-
cellular and serum micronutrient analysis.Micronutrient deficiencies in serum before and after LCD
Baseline deficiencies in serum micronutrient concentra-
tions were observed for 25(OH)D, vitamin C, selenium
and iron (Table 5). Except for 25(OH)D, the number of
cases with deficiencies either remained (selenium, iron,
both n.s.) or tended to further increase, which was the
case for vitamin C (+15% of subjects with deficiency, n.s.).n (dietary record analysis) and a subgroup undergoing
LCD intervention
group (n = 32)
LCD intervention subgroup (follow-up
until program end) (n = 9)
12.5 33.3
87.5 66.7
47.0 ± 10.23 48.9 ± 8.94
118.4 ± 19.93 125.5 ± 22.54
41.8 ± 7.21 43.0 ± 6.42
Table 3 Weight loss during low-calorie diet (n = 32) and














group (n = 32)
19.5 ± 5.65 16.2 ± 3.24
LCD intervention
subgroupa (n = 9)
21.8 ± 8.41 17.0 ± 4.12 19.9 ± 15.0 15.5 ± 10.6
afollow-up until program end.
Abbreviations: WL Weight loss, RWL Relative weight loss.
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(7.7%) and calcium (53.8%) occurred. Figure 1 shows
serum concentrations that decreased (calcium (p< 0.01)
and iron (p< 0.05)) or increased (25(OH)D (p< 0.01), fol-
ate (p< 0.05) and zinc (p< 0.01)), or remained unchanged
(vitamin C (n.s.)) in the course of intervention using for-
mula diet.
Micronutrient deficiencies in BMC before and after LCD
Intracellular antioxidant status in BMC is displayed in
Figure 2. Before intervention, deficiencies were observedTable 4 Micronutrient intake of the obese study population c
Female subjects (n = 76)







Retinol [μg] 800 629.0 ± 76.57 600.0 ± 0.01 ns
β-Carotene [mg] 4.8 3.0 ± 0.24 5.4 ± 0.04 <.001
Vitamin D [μg] 5 2.5 ± 0.32 2.9 ± 0.03 <.05
Vitamin E [mg] 12 11.7 ± 0.56 13.4 ± 0.08 <.05
Vitamin B1 [mg] 1 1.2 ± 0.04 1.3 ± 0.01 ns
Vitamin B2 [mg] 1.2 1.4 ± 0.04 1.7 ± 0.01 <.05
Niacin-equivalent [mg] 13 31.2 ± 0.98 28.6 ± 0.13 ns
Vitamin B6 [mg] 1.2 1.5 ± 0.04 2.0 ± 0.01 <.001
Folate-equivalent [μg] 400 215.2 ± 8.07 290.0 ± 1.94 <.001
Vitamin B12 [μg] 3 4.9 ± 0.31 4.3 ± 0.02 ns
Vitamin C [mg] 100 92.1 ± 5.30 152.0 ± 0.95 <.001
Sodium [g] 550 3321.7 ± 119.01 2494.0 ± 9.41 <.001
Potassium [mg] 2000 2649.1 ± 72.92 3243.0 ± 11.29 <.001
Calcium [mg] 1000 979.9 ± 46.72 1019.0 ± 4.33 ns
Magnesium [mg] 300 365.2 ± 12.23 376.0 ± 1.23 ns
Iron [mg] 15 12.9 ± 0.36 12.3 ± 0.04 ns
Zinc [mg] 7 12.0 ± 0.36 9.5 ± 0.03 <.001
Iodine [μg] 200 83.9 ± 4.08 98.0 ± 0.45 ns
Abbreviations: DRI =Dietary Reference Intake, NNS II = National Nutrition Survey II.
Data are presented as mean ± SE.
a Recommendations for nutrient intake in Germany, Austria and Switzerland (D-A-C
b Obese study population compared to German reference population (NNS II).for vitamin C (63.3%), ß-carotene (20.0%) and lycopene
(10.0%). After the LCD period BMC concentrations of
vitamin C (p< 0.05) and lycopene (p< 0.05) decreased,
resulting in a higher percentage of subjects with defi-
ciencies (vitamin C +30.2%, p< 0.01 and lycopene
+6.1%, n.s.). At the end of the weight loss program
(9 months after termination of the formula diet) antioxi-
dative status was optimal or even above reference range,
except for vitamin C (deficiencies in 77.8% of subjects),
which also tended to improve (n.s.).Vitamin C in serum, BMC and leukocytes before and after
LCD
No correlation between vitamin C serum, BMC and
leukocyte concentrations was observed. Serum and BMC
vitamin C levels tended to decrease during the formula
period (serum 59.44 ± 22.73 μmol/l before intervention,
37.29 ± 13.48 μmol/l after formula diet (n.s.), BMC
6.62 ± 1.52 pmol/μg DNA and 2.95 ± 1.10 pmol/μg DNA
(p< 0.001), respectively), whereas leukocyte vitamin C
concentrations increased (81.64 ± 16.30 ng/108 cells to
111.2 ± 36.32 ng/108 cells, p< 0.05) (Figure 3).ompared to DRI and the reference population








P b Obese subjects
[%] below DRI
86 1000 594.2 ± 55.92 1000.0 ± 0.01 <.001 89
86 6 2.7 ± 0.31 5.1 ± 0.04 <.001 93
87 5 2.4 ± 0.31 3.8 ± 0.04 <.001 93
55 14 11.4 ± 0.80 16.0 ± 0.12 <.05 75
25 1.2 1.4 ± 0.10 1.8 ± 0.01 <.05 39
33 1.4 1.5 ± 0.09 2.2 ± 0.02 <.01 39
0 16 34.9 ± 1.67 39.8 ± 0.22 ns 0
24 1.5 1.7 ± 0.09 2.6 ± 0.02 <.01 43
99 400 213.4 ± 11.07 338.0 ± 3.09 <.001 100
30 3 5.7 ± 0.36 6.5 ± 0.04 ns 4
66 100 86.2 ± 8.50 152.0 ± 1.14 <.001 71
0 550 3981.6 ± 246.13 3458.0 ± 15.72 <.05 0
14 2000 2757.2 ± 146.67 3789.0 ± 15.06 <.001 11
63 1000 1020.4 ± 75.47 1143.0 ± 5.93 ns 61
29 350 380.9 ± 23.01 452.0 ± 1.74 <.05 46
78 10 14.7 ± 0.79 15.2 ± 0.06 ns 7
3 10 14.2 ± 0.71 12.3 ± 0.05 <.05 4
99 200 92.8 ± 6.67 107.0 ± 0.5 ns 100
H reference values)[18].
Table 5 Serum micronutrient levels and deficiencies in obese subjects before and after low-calorie diet (n = 14)
Before formula diet After formula diet
Mean± SD Deficiency [%] Mean± SD Deficiency [%] pa
Vitamin A [mg/l] 0.67 ± 0.19 0 0.78 ± 0.22 0 n.s.
Vitamin E [mg/l] 11.57 ± 4.31 0 12.54 ± 2.66 0 n.s.
25(OH)D [ng/ml] 17.22 ± 4.02 57.1 24.32 ± 7.25 30.8 <.01
Vitamin C [mg/l] 52.01 ± 10.65 10.0 43.86 ± 15.96 25.0 n.s.
Vitamin B12 [pg/ml] 474.1 ± 155.3 0 528.3 ± 165.3 0 n.s.
Folate [ng/ml] 10.51 ± 4.7 0 15.42 ± 4.9 0 <.05
Selenium [μg/l] 87.71 ± 11.74 14.3 95.42 ± 18.67 16.7 <.05
Iron [μg/dl] 81.50 ± 35.05 14.3 61.62 ± 26.17) 15.4 <.05
Zinc [μg/dl] 82.14 ± 10.64 0 94.85 ± 13.80 7.7 <.01
Calcium [mmol/l] 2.44 ± 0.10 0 2.18 ± 0.28 53.8 <.01
a p-values were calculated in relation to absolute values using paired t-tests.
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and body fat
CRP concentrations positively correlated with body
weight (r = 0.6558, p< 0.0001). There was a negative cor-
relation between iron and CRP (r =−0.456, p< 0.05).
Lipophilic vitamins were negatively associated with body
fat in percent of total body weight (25(OH)D:
r =−0,6369, p< 0.0001, vitamin A: r =−0,4663, p< 0.05,
vitamin E (serum): r =−0,4378, p< 0.05).
Discussion
The present study clearly confirms previous observations
stating that obese individuals are characterized by
micronutrient deficiencies [4,6-8,10-13]. The deficiencies
are suggested by both low intake and low serum and
intracellular levels as shown by our data.
The study demonstrates an insufficient dietary micro-
nutrient supply of retinol, ß-carotene, vitamin D, vitamin
E, vitamin C, folate, iron, and calcium in obese indivi-
duals. A highly significant difference compared to the
reference population, both in men and women, was
observed for ß-carotene, folate, vitamin C, and fiber -
nutrients which are essentially found in fruits, vegetables
and whole-grain products, thus pointing to an unba-
lanced diet leading to micronutrient deficiencies.
Evaluation of nutritional intake has some methodo-
logical weakness such as underreporting that limits the
interpretation of dietary record data. The resulting
error is possibly even more distinct in obese subjects
[21-24]. However, underreporting especially applies to
carbohydrate-rich snacks [25], which are low in micronu-
trient content by nature, and not to ‘healthy’ food. There-
fore we assume that this error is negligible regarding
micronutrient intake.
Before intervention, obese subjects showed deficiencies
of several micronutrients in serum or BMC, namely 25
(OH) vitamin D, vitamin C, selenium, iron, ß-caroteneand lycopene. We did not find any statistically significant
correlation between micronutrient intake and serum or
BMC concentrations, which could be due to the limited
subject number. However, the reported intakes of ß-
carotene, vitamin D, vitamin C, and iron were clearly
below DRI and point to a relation between micronu-
trient intake and body micronutrient status.
Based on our data, we conclude that a DRI-covering
low-calorie formula diet does not meet the demands of
obese individuals. The reasons can be manifold and
could cover metabolic alterations during a period of
major weight loss, unbalanced dispersal of lipophilic
compounds and fat-tissue specific oxidative stress. In-
deed, we observed even more subjects with deficiencies
in some micronutrients after a three-month period of
formula diet compared to the baseline status before
intervention. In particular, vitamin C, selenium, iron,
zinc, and lycopene deficiencies increased or could not be
corrected by protein-rich formula diet containing vita-
mins and minerals according to DRI. The formula meal
replacement products contained micronutrients in
amounts often even higher than those recommended for
the general population. We also observed an increase in
subjects with calcium deficiency. However, serum cal-
cium concentration is not an adequate measure for diet-
ary calcium intake, but indicates an electrolyte
imbalance induced by weight loss and accompanying
fluid changes in the body.
Possible interaction effects between pharmaceuticals
and micronutrients have to be considered, which may
account for increased demands. Within this study, fre-
quency and dosage of drug use did not change during
the LCD period in most of the cases and thus most
likely did not confound the results. In 36% of the sub-
jects the dosage of at least one drug was slightly
reduced, which would, if anything, have improved
micronutrient bioavailability.
Figure 1 Serum micronutrients levels that decreased (a) or increased (b) in the course of intervention using a DRI- covering low-calorie
formula diet (n = 14). The dotted lines indicate the reference limits for adequate serum levels. Data are presented as median +/− quartiles
(boxes) and 1.5 interquartile ranges (whiskers).
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tween vitamin E in serum and BMC, but the decrease in
BMC concentrations could point to the fact that intra-
cellular levels respond more sensitively to altered oxida-
tive stress, which particularly occurs in a period of major
weight loss [26]. This is explained by an upregulation of
the renin-angiotensin system and a reduction ofglutathione and glutathione peroxidase in erythrocytes,
resulting in higher concentrations of reactive oxygen
species which again promote the metabolic syndrome
[6]. All three lipophilic vitamins negatively correlated
with total body fat, assessed by bioelectric impedance
analysis. This is most likely due to the storage capacity
for lipophilic compounds, which is so far only suggested
Figure 2 Intraepithelial micronutrient levels before and after obesity therapy using a low-calorie formula diet (n = 32) and during
further follow-up (n = 9). Samples with no detectable micronutrient levels were excluded in this analysis. Data are presented as median
+/− quartiles (boxes) and 1.5 interquartile ranges (whiskers). The dotted lines indicate the reference ranges. Statistical analysis: paired t-test.
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http://www.nutritionj.com/content/11/1/34for 25(OH)D [27,28]. It is tempting to speculate that this
also applies to other lipophilic compounds. Thus, a
higher amount of fat tissue could lead to an increase in
accumulation of lipophilic vitamins, which in turn are
lacking in the serum pool. The positive association be-
tween adipose tissue mass and systemic 25(OH)D con-
centrations, the almost 2fold reduction of 25(OH)D
deficiency following LCD, and the significant increase in
25(OH)D serum concentrations observed in our study
all suggest storage in adipose tissue and release during
weight loss, also described elsewhere [29,30].Figure 3 Comparison of vitamin C levels determined in serum (a) or i
blood leukocytes (c), of obese patients who underwent a DRI-coverin
indicate the reference limits for adequate serum levels, the continuous line
according to reference data from healthy populations. Data are presented
BMC samples below detection level were excluded from this analysis.McClung et al. [31] hypothesized that obesity influ-
ences iron absorption by inflammatory mediated
mechanisms. Proinflammatory cytokines promote hepci-
din release in liver and fat tissue, which is involved in
iron homeostasis, inhibiting absorption in enterocytes
[31]. This hypothesis is supported by a significantly
negative correlation of iron concentration with CRP
levels observed in our obese subjects.
Measurement of vitamins in blood samples might not re-
flect the amount of vitamins absorbed or the concentration
in tissues [32,33]. To gain information on body distributionntracellular, either in buccal epithelial cells (b) or in peripheral
g low-calorie formula diet program (n = 14). The dotted lines
separates the ’low level range’ from ’manifest deficiency range’
as median +/− quartiles (boxes) and 1.5 interquartile ranges (whiskers).
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http://www.nutritionj.com/content/11/1/34we monitored both serum and intracellular levels of vita-
mins. BMC are easily available and serve as a model system
for assessment of the nutritional and antioxidative status,
as well as to control for the success of supplementation
and effect of medicamentous therapies [33-35]. With a cel-
lular turnover of 5 to 25 days, BMC are supposed to reflect
the current cellular supply [36].
We evaluated the level of vitamin C, lycopene, α-
tocopherol, and ß-carotene and thus the antioxidative cap-
acity directly in BMC. These dietary-derived antioxidants
are an important component to support the exogenous
antioxidative system [33]. Except for ß-carotene and α-
tocopherol, which were only slightly reduced, we observed
a significant decrease in vitamin C and lycopene during
the three-month formula diet suggesting again an
enhanced oxidative stress in obese individuals and thus a
higher demand of antioxidative vitamins compared to
healthy, normal weight subjects, especially in a period of
major weight loss.
The current choices for functional markers of vitamin C
status are vitamin C concentrations in plasma and leuko-
cytes. Plasma or serum vitamin C levels are highly sensitive
to recent dietary intakes, but may not reflect tissue content
as well as leukocyte levels [37,38]. Serum vitamin C con-
centrations remained unchanged during the vitamin C
enriched formula diet, whereas leukocyte levels improved.
Leukocyte concentrations more reliably display long-term
supply and deficiencies [37,38]. Bioavailability of vitamin C
is a complex issue involving distribution to the tissues and
utilization by the tissues [35]. Before intervention,
leukocyte levels were depleted and might replete preferen-
tially due to their high metabolic priority [37]. Contrary to
our expectations intracellular vitamin C concentrations in
BMC significantly decreased. To obtain a state of complete
saturation, the repletion dynamics of vitamin C in certain
tissues may be more specific than others when the vitamin
intake during repletion is limited [37]. However, the results
should be interpreted carefully because of the small sample
size, the variation of vitamin C content throughout cell
types and the reliability of sampling and analysis procedure
due to the unstable nature of vitamin C. In contrast to the
fat-soluble antioxidants α-tocopherol, lycopene and ß-
carotene, which were demonstrated to be reliable markers
in BMC [32,33,35,39,40], the capacity of BMC vitamin C
concentrations and its reliability as a biomarker for vita-
min C status has not been described so far.
Interestingly, we observed a significant increase in all
antioxidants measured in BMC at the end of the pro-
gram year. This subgroup only included nine subjects,
but suggests a change in dietary habits following inten-
sive weight reduction and diet counseling. These sub-
jects were successful in losing weight and were able to
maintain this weight after the formula diet, therefore
most likely putting their nutritional knowledge intopractice. However, this finding needs to be confirmed
by other studies.
A potential limitation of the study is that the dietary as-
sessment strategies differed in the two study populations.
In the NNSII a comprehensive dietary history method in-
cluding cross-check features was used. The dietary record
approach in this study was chosen to provide quantita-
tively accurate information on food consumption as well
as influence of food processing, but may be biased due to
the estimation of the weight of food consumed in some
cases instead of weighing, and also by affecting eating be-
havior. Moreover, for several micronutrients simple blood
concentrations were measured, which might not always
reflect a complete picture of the nutritional status. At this
stage we only included a small sample size, which limits
the explanatory power of the study results.
Conclusions
To the best of our knowledge, this is the first report ana-
lyzing if DRI of micronutrients meet the demands of
obese individuals consuming a standardized LCD diet.
Our pilot study provides evidence that a poor micronu-
trient status in obesity is not only caused by intakes that
are below the DRI. A formula diet providing 100% of
micronutrients according to DRI did not cover the
demands of some micronutrients in obese subjects. This
can be explained by metabolic alterations during a
period of major weight loss, unbalanced dispersal of
lipophilic compounds and fat-tissue specific oxidative
stress. The underlying mechanisms should be further
addressed, as well as whether obese individuals receiving
an energy-balanced DRI-covering diet also manifest
micronutrient deficiencies.
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